Treatment of these Huh7 and PLC8024 HCC cell lines with Dox or 5-FU resulted in increased selection for chemoresistant CD133+ cells that expressed higher levels of both activated phosphorylated and BCL-2. The gene discussed is BCL2; the disease is hepatocellular carcinoma.